
Subsidiary13 Apr 2026, 03:30 pm
Mankind Pharma Board Approves Winding Up Sri Lankan Subsidiary
AI Summary
Mankind Pharma's Board of Directors approved the closure and winding up of its wholly-owned subsidiary, Mankind Pharma Lanka (Private) Limited, incorporated in Sri Lanka. This decision was made because changed regulatory requirements rendered the anticipated business objectives unviable. The company clarified that the subsidiary had no business operations and is not considered a material subsidiary, as per Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Key Highlights
- Board approved winding up of Mankind Pharma Lanka (Private) Limited.
- Closure due to changed regulatory requirements making business unviable.
- The Sri Lankan WOS had no business operations.
- The subsidiary is not considered a material subsidiary of the company.
Price Impact
More from MANKIND